What's the difference between normal and optimal blood ranges?

Normal blood ranges indicate absence of disease, while optimal ranges target peak health and longevity. Understanding this distinction helps you move beyond just avoiding illness to actively optimizing your health through personalized biomarker tracking.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the gap between 'normal' and 'optimal'

When you receive your blood test results, your doctor typically tells you everything looks 'normal' if your values fall within the standard reference ranges. But here's what many people don't realize: normal doesn't necessarily mean optimal. While normal ranges help identify disease, optimal ranges help you achieve peak health and longevity.

The distinction between normal and optimal blood ranges represents a fundamental shift in how we approach health. Normal ranges are designed to identify illness, while optimal ranges are designed to promote wellness. This difference can have profound implications for your energy levels, disease risk, and overall quality of life as you age.

How standard reference ranges are determined

Standard reference ranges are typically established by testing large populations and determining where 95% of 'healthy' people fall. This statistical approach means that values are considered normal if they fall between the 2.5th and 97.5th percentiles of the tested population. However, this method has several important limitations that affect how we should interpret our results.

Normal vs Optimal Ranges for Key Metabolic Markers

BiomarkerNormal RangeOptimal RangeHealth Impact
Fasting GlucoseFasting Glucose<100 mg/dL70-85 mg/dLLower diabetes and cardiovascular risk
Hemoglobin A1cHemoglobin A1c<5.7%<5.3%Better long-term glucose control
Fasting InsulinFasting Insulin<25 μIU/mL2-5 μIU/mLImproved insulin sensitivity
TriglyceridesTriglycerides<150 mg/dL<100 mg/dLReduced metabolic syndrome risk

Optimal ranges are based on research showing lowest disease risk and best health outcomes.

Population-based limitations

The populations used to establish reference ranges often include people who aren't truly healthy. Many have undiagnosed conditions, poor lifestyle habits, or early-stage diseases that haven't yet manifested symptoms. As our population becomes less healthy overall, these 'normal' ranges can shift to accommodate declining health standards rather than optimal function.

One-size-fits-all approach

Standard ranges rarely account for individual factors like age, sex, ethnicity, body composition, or lifestyle. A 'normal' testosterone level for a 70-year-old man would be considered low for a 30-year-old, yet many labs use the same reference range for all adult males. This oversimplification can miss important health optimization opportunities.

Why optimal ranges matter for longevity

Optimal ranges are based on research showing which biomarker levels are associated with the best health outcomes, lowest disease risk, and greatest longevity. These ranges often fall within the normal range but represent a narrower target that's associated with peak function rather than just absence of disease.

For example, while a fasting glucose of 99 mg/dL is technically 'normal,' research shows that people with fasting glucose levels between 70-85 mg/dL have significantly lower risks of developing diabetes, cardiovascular disease, and other metabolic conditions. By targeting optimal ranges, you can identify and address health risks years or even decades before they would show up as abnormal on standard tests.

Early detection and prevention

Many chronic diseases develop slowly over years or decades. By the time your biomarkers fall outside the normal range, significant damage may have already occurred. Optimal ranges help you catch these trends early, when lifestyle interventions are most effective and can potentially reverse the trajectory entirely.

Key biomarkers where optimal differs from normal

Understanding which biomarkers have the biggest gaps between normal and optimal ranges can help you prioritize your health optimization efforts. Here are some of the most important examples where targeting optimal levels can make a significant difference in your health outcomes.

Metabolic health markers

Fasting glucose provides a perfect example of the normal versus optimal distinction. While levels up to 99 mg/dL are considered normal, and 100-125 mg/dL is labeled 'prediabetes,' research suggests optimal levels are between 70-85 mg/dL. Similarly, hemoglobin A1c is normal below 5.7%, but optimal levels for longevity are typically below 5.3%.

Insulin resistance often develops years before glucose levels become abnormal. Testing fasting insulin, which has an optimal range of 2-5 μIU/mL versus a normal range up to 25 μIU/mL, can reveal metabolic dysfunction much earlier than glucose tests alone.

Cardiovascular markers

Traditional cholesterol testing often misses important cardiovascular risk factors. While LDL cholesterol below 100 mg/dL is considered normal, optimal levels for heart health are often below 70 mg/dL. More importantly, advanced markers like ApoB (optimal below 80 mg/dL) and Lp(a) provide better risk assessment than standard cholesterol panels.

Hormone optimization

Hormone reference ranges are particularly problematic because they often encompass such a wide range. For example, testosterone in men can be 'normal' anywhere from 300-1000 ng/dL, but many men experience optimal energy, mood, and body composition with levels above 600 ng/dL. Similarly, thyroid markers like TSH have a normal range of 0.4-4.5 mIU/L, but many people feel best with TSH between 1.0-2.0 mIU/L.

How to interpret your results through an optimization lens

Shifting from a disease-prevention mindset to a health-optimization approach requires a new way of looking at your blood test results. Instead of simply checking whether values fall within normal ranges, you should evaluate where they fall within those ranges and whether they're trending toward or away from optimal levels.

The most powerful approach combines regular testing with trend analysis. A biomarker that's technically normal but has increased by 30% over the past year might indicate a developing problem. Conversely, seeing your markers move toward optimal ranges confirms that your health interventions are working. For comprehensive biomarker tracking and personalized optimization insights, consider using SiPhox Health's free upload service to analyze your existing lab results or try Sai, our AI health optimization expert.

Taking action: Moving from normal to optimal

Achieving optimal biomarker levels typically requires a more proactive approach than simply avoiding disease. This means implementing targeted lifestyle interventions, tracking your progress regularly, and making adjustments based on your results rather than waiting for problems to develop.

Personalized optimization strategies

What works for optimizing one person's biomarkers may not work for another. Factors like genetics, current health status, lifestyle, and even microbiome composition all influence how you respond to different interventions. This is why personalized testing and tracking are so valuable - they help you identify what specifically moves your markers in the right direction.

  • Dietary modifications based on your metabolic markers
  • Exercise protocols tailored to your cardiovascular and hormonal profile
  • Sleep optimization when stress hormones are suboptimal
  • Targeted supplementation for specific deficiencies
  • Stress management techniques when inflammatory markers are elevated

The importance of regular monitoring

Optimizing your biomarkers isn't a one-time event - it's an ongoing process that requires regular monitoring and adjustment. Testing every 3-6 months allows you to track trends, evaluate the effectiveness of your interventions, and make data-driven decisions about your health. This frequency also helps you catch any negative changes quickly before they become problematic.

Leveraging AI for personalized health insights

Modern AI technology has revolutionized how we can interpret and act on blood test results. Unlike generic reference ranges, AI can analyze your results in the context of your complete health profile, identifying patterns and providing personalized recommendations that consider your unique circumstances.

Sai, SiPhox Health's AI health optimization expert, goes beyond simple range checking to provide comprehensive analysis of your biomarkers. By considering factors like your age, sex, health goals, and previous results, Sai can identify optimization opportunities that standard lab reports miss. The platform also integrates data from wearables, lifestyle tracking, and body composition scans to provide truly holistic health insights.

For those who already have blood test results from other providers, SiPhox Health's free upload service allows you to transform confusing lab reports into clear, actionable insights. The AI-powered analysis helps you understand not just whether your results are normal, but how to optimize them for better health outcomes.

The future of personalized health optimization

As our understanding of human biology deepens and AI technology advances, the gap between normal and optimal ranges becomes increasingly important. We're moving toward a future where health optimization is personalized not just to demographic categories, but to individual genetic profiles, lifestyle factors, and health goals.

This shift represents a fundamental change in healthcare - from a reactive model that waits for disease to develop, to a proactive approach that optimizes health throughout life. By understanding and targeting optimal ranges rather than settling for normal, you can take control of your health trajectory and maximize both your healthspan and lifespan.

The tools to make this shift are now more accessible than ever. Whether you're just beginning your health optimization journey or looking to take your wellness to the next level, understanding the difference between normal and optimal ranges is the first step toward achieving your best possible health.

References

  1. Dugani, S. B., Moorthy, M. V., Li, C., Demler, O. V., Alsheikh-Ali, A. A., Ridker, P. M., ... & Mora, S. (2021). Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident coronary heart disease in women. JAMA Cardiology, 6(4), 437-447.[PubMed][DOI]
  2. Nordestgaard, B. G., & Langlois, M. R. (2022). Which lipids should be analyzed for diagnostic workup and follow-up of patients with hyperlipidemias? Current Cardiology Reports, 24(9), 1101-1111.[PubMed][DOI]
  3. Echouffo-Tcheugui, J. B., & Selvin, E. (2021). Prediabetes and what it means: the epidemiological evidence. Annual Review of Public Health, 42, 59-77.[PubMed][DOI]
  4. Kaufman, J. M., & Vermeulen, A. (2023). The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocrine Reviews, 44(2), 193-220.[PubMed][DOI]
  5. Razvi, S., Jabbar, A., Pingitore, A., Danzi, S., Biondi, B., Klein, I., ... & Iervasi, G. (2018). Thyroid hormones and cardiovascular function and diseases. Journal of the American College of Cardiology, 71(16), 1781-1796.[PubMed][DOI]
  6. Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012). Prediabetes: a high-risk state for diabetes development. The Lancet, 379(9833), 2279-2290.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my biomarkers at home?

You can test your biomarkers at home with SiPhox Health's Core Health Program, which includes 25 essential biomarkers covering metabolic, cardiovascular, and hormonal health. For more comprehensive testing, the Ultimate 360 Health Program offers 50 biomarkers with expert review and personalized recommendations.

What's the difference between reference ranges and optimal ranges?

Reference ranges are statistical averages that identify disease (typically 2.5th to 97.5th percentile of the population), while optimal ranges are narrower targets associated with the best health outcomes, lowest disease risk, and greatest longevity based on research studies.

Can I upload my existing blood test results for optimal range analysis?

Yes, you can use SiPhox Health's free upload service to transform your existing lab reports into clear, personalized insights. The AI-powered analysis shows not just whether your results are normal, but provides optimization recommendations based on your unique profile.

How often should I test my biomarkers for optimization?

For health optimization, testing every 3-6 months is ideal. This frequency allows you to track trends, evaluate the effectiveness of your interventions, and make timely adjustments to your health strategies before small changes become significant issues.

Which biomarkers show the biggest difference between normal and optimal ranges?

Key biomarkers with significant gaps include fasting glucose (normal <100 vs optimal 70-85 mg/dL), fasting insulin (normal <25 vs optimal 2-5 μIU/mL), TSH (normal 0.4-4.5 vs optimal 1.0-2.0 mIU/L), and testosterone in men (normal 300-1000 vs optimal >600 ng/dL).

How does Sai help with biomarker optimization?

Sai, SiPhox Health's AI health optimization expert, analyzes your biomarkers in context with your complete health profile, providing personalized recommendations that go beyond generic reference ranges. Sai integrates data from blood tests, wearables, and lifestyle tracking for comprehensive health insights.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details